Effectiveness of a Team-based Follow-up Program in General Practice Among People With Chronic Conditions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

228 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-19

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will develop and evaluate the effectiveness of a team-based follow-up program in general practice (GP) among people with chronic conditions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Digital Follow-up Program for People with Chronic Obstructive Pulmonary Disease in Primary Healthcare

NCT06401512

COPD Chronic Obstructive Pulmonary Disease

RECRUITING NA

Effects of an Active Implementation of a Guideline for Chronic Obstructive Pulmonary Disease

NCT01228708

Implementation of a Chronic Disease Management Programme COPD

COMPLETED NA

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

NCT00705302

Chronic Obstructive Pulmonary Disease (COPD)

COMPLETED NA

Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

NCT00159549

Chronic Obstructive Pulmonary Disease

COMPLETED NA

A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease

NCT06850961

Chronic Obstructive Pulmonary Disease (COPD) Self-management Mobile Application +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The epidemic proportion of lifestyle related non-communicable diseases is a worldwide challenge and public health problem resulting in significant hospitalization rates, mortality and morbidity, and huge personal and societal costs. This project involves research for better public health and health outcomes acknowledging the need for improvements in the health-care services in the prevention of risks and harm and better risk-factor management. We will conduct a randomized control study in four GP practices with ≥3 GPs and ≥one nurse among 154 people at risk for developing Type 2 Diabetes Mellitus (T2DM) or manifest disease, and 154 people in the control group. Inclusion criteria are Diabetes Risc Calculator (FINDRISC) ≥ 15 or HbA1c ≥6,5 % or specific need for individualized follow up such as Body Mass Index (BMI) ≥ 30. In addition, we will conduct a feasibility study among 30 people with risk for Chronic Pulmonary disease (COPD) or manifest disease. The study has the following two objectives: 1) to evaluate the effectiveness of a team-based follow-up program among people with risk for T2DM or manifest T2DM with the use of Guided Self-Determination (GSD) as an empowerment approach for patients in general practice, 2) to test the feasibility and pilot a team-based follow-up program among people with risk for COPD or manifest COPD with the use of GSD as an empowerment approach for patients in general practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Type 2 COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Team-based consultations

Guided Self-Determination

Group Type EXPERIMENTAL

Guided Self-Determination

Intervention Type BEHAVIORAL

Structured team-based consultations

Standard care

Standard consultation

Group Type EXPERIMENTAL

Standard care

Intervention Type BEHAVIORAL

Standard consultations

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guided Self-Determination

Structured team-based consultations

Intervention Type BEHAVIORAL

Standard care

Standard consultations

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 20-80 years with FINDRISC score ≥15
* Body Mass Index ≥ 30
* Manifest T2DM (HbA1c ≥48 mmol/mol (6,5%))
* Positive smoking status (risk for COPD)
* Manifest COPD (spirometry value: FEV1/FVC \< 0,7).

Exclusion Criteria

* Severe somatic disease (cancer, end stage renal disease)
* Severe psychiatric diagnosis or dementia
* Patients who do not understand nor speak Norwegian.

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No